100 UG RP LILRA2
|
Invitrogen Human LILRA2 (CD85h, ILT1) His-tag Recombinant Protein, Quantity: 100 ug,0,0,0,0, Accession Number: Q8N149,0,0,0,0, Endotoxin Concentration: <1.0 EU/ ug,0,0,0,0, Expression System: HEK293 cells,0,0,0,0, Format: Lyophilized,0,0,0,0, Formula
|
3136-RP88111
|
EA
|
|
1 MG RP LILRA2
|
Invitrogen Human LILRA2 (CD85h, ILT1) His-tag Recombinant Protein, Quantity: 1 mg,0,0,0,0, Accession Number: Q8N149,0,0,0,0, Endotoxin Concentration: <1.0 EU/ ug,0,0,0,0, Expression System: HEK293 cells,0,0,0,0, Format: Lyophilized,0,0,0,0, Formulati
|
3136-RP88112
|
EA
|
|
1 MG RP LILRA2
|
Invitrogen Human LILRA2 (CD85h, ILT1) Fc Chimera Recombinant Protein, Quantity: 1 mg,0,0,0,0, Accession Number: Q8N149,0,0,0,0, Endotoxin Concentration: <1.0 EU/ ug,0,0,0,0, Expression System: HEK293 cells,0,0,0,0, Format: Lyophilized,0,0,0,0, Formul
|
3136-RP88114
|
EA
|
|
100 UG RP CD200
|
Invitrogen Human CD200 His-tag Recombinant Protein, Quantity: 100 ug,0,0,0,0, Accession Number: P41217,0,0,0,0, Activity: Immobilized CD200 Protein, Human, Recombinant (His Tag) (at 2 ug/mL (100 uL/well) can bind CD200R Protein, Human, Recombinant (H
|
3136-RP87980
|
EA
|
|
100 UG RP CD36
|
Invitrogen Human CD36 (SR-B3) His-tag Recombinant Protein, Quantity: 100 ug,0,0,0,0, Accession Number: P16671,0,0,0,0, Endotoxin Concentration: <1.0 EU/ ug,0,0,0,0, Expression System: HEK293 cells,0,0,0,0, Format: Lyophilized,0,0,0,0, Formulation: PB
|
3136-RP87994
|
EA
|
|